ROUTE/

NAME OF DRUG/ MECHANISM OF INDICATIO CONTRAIND SIDE NURSING

DOSAGE/
MEDICATION ACTION N ICATION EFFECT RESPONSIBILITY
FREQUENCY
GENERIC ROUTE: Erythromycin To prevent Erythromycin EENT: NURSING
NAME: Topical inhibits protein ophthalmia is Minor CONSIDERATION
Erythromycin synthesis; usually neonatorum contraindicat ocular
bacteriostatic, but caused by ed in patients irritations 1. Observe 10 R’s in
BRAND NAME: DOSAGE: may be bactericidal Neisseria hypersensitiv and giving medication.
Erygel 0.5% in high gonorrhea or e to the drug. redness. 2. Wash hands before
concentrations or Chlamydia and after
against highly trachomatis. SKIN: application.
susceptible Reference: Burning, 3. Wash, rinse and
CLASSIFICATIO FREQUENCY organisms. Reference: Nursing drug dryness, dry face before
N: : Nursing handbook pruritus, each topical use.
Macrolide After birth Reference: drug 2021 erythema, 4. Assess allergic
antibiotics Nursing drug handbook irritation, reactions.
handbook 2021 2021 oily skin, 5. Clean the patients’
peeling, eye for excessive
sensitivity discharge before
reactions. application.
6. Do not touch the
OTHER: tip of the applicator
Hypersens to eye or
itivity surrounding tissue.
 reactions.
PATIENT
Reference /PARENTS
: Nursing TEACHING
drug 7. Tell the patients’
handbook mother to watch for
2021 and report signs
and symptoms of
sensitivity (itching
lids, redness,
swelling, or
constant burning of
eyes or skin)
8. Advise the mother
to report diarrhea
frequently.
9. Explain to the
parents the
rationale/ purpose
of administering
erythromycin.

NAME OF ROUTE/
MECHANISM CONTRAIN SIDE NURSING
DRUG/ DOSAGE/ INDICATION
OF ACTION DICATION EFFECT RESPONSIBILITY
MEDICATION FREQUENCY
GENERIC ROUTE: As a component  Prevention Phytonadio Immune: NURSING
NAME: Parenteral of an enzyme and ne is anaphylaxis CONSIDERATION
Vitamin K (IM) system, vitamin treatment of contraindic after
K1 promotes vitamin K ated in parenteral 1. Observe 10 R’s in
BRAND DOSAGE: the formation of deficiency patients use reported giving medication.
NAME: 0.1 ml coagulation bleeding, with 2. Wash hands before
Phytomenadion factors II including hypersensit Integument and after application.
e (prothrombin), hemorrhagic ivity to ary: 3. Route of
VII, IX and X disease of phytonadio irritation at administration o IM
CLASSIFICA FREQUENC and of the ne or injection site is the preferred
the newborn.
TION: Y: coagulation inactive route.
Vitamins/ 1 hour after inhibitors Reference: ingredients Nervous: 4. Assess allergic
hemostatic birth protein C and Neonatal of the facial reactions.
agent protein S1 medicine: product. flushing, 5. Consider
Phytomendaion Biliary sweating implementing a local
Reference: e (Vitamin K) tract protocol to aid
Neonatal (health.qld.gov. disease, identification of IM
medicine: au) hepatic injection sites (e.g.
Phytomendaion disease, vitamin K1 into left
e (Vitamin K) jaundice thigh,
(health.qld.gov.
au) Reference: PATIENT / PARENT
www.pdr.n TEACHING
et/drug- 6. Explain to the
summary/ parents the rationale/
Phytonadio pupose of
ne- administering hepa
 phytonadio B.
ne-780

ROUTE/
NAME OF DRUG/ MECHANISM CONTRAINDI SIDE NURSING
DOSAGE/ INDICATION
MEDICATION OF ACTION CATION EFFECT RESPONSIBILITY
FREQUENCY
GENERIC ROUTE: Suspension of To promote History of Body NURSING
NAME: Parenteral inactivated and active allergic Whole: CONSIDERATION
Hepatitis B (IM) purified immunity in reaction to
vaccine hepatitis B individuals at hepatitis B Mild local 1. Observe 10 R’s in
BRAND NAME: DOSAGE: surface antigen high risk of vaccine or to tenderness giving medication.
Recombivax HB 0.5 ml (HBsAg) potential any ingredient at injection 2. Wash hands
derived from exposure to in the site, local before and after
human plasma hepatitis B formulation; inflammator administration.
CLASSIFICATI FREQUENC of screened virus or HBsAg y reaction 3. Assess allergic
ON: Y: asymptomatic HBsAg- carriers. Safe (swelling, reactions.
Vaccines Within 24 HBsAg-positive positive use during heat, 4. Consider
hours of birth carriers of materials. Has pregnancy redness, implementing a
hepatitis B been used (category C) induration, local protocol to
virus. Hepatitissimultaneousl and lactation pain); fever, aid identification
B vaccine y (into is not malaise, of IM injection
recombinant is different sites) established. fatigue, sites (e.g. hepatitis
the first vaccine
with hepatitis headache, B vaccine into
produced by B immune Reference: dizziness, right thigh,
gene splicing. globulin (H- https:// faintness,
No human BIG) for post- www.bing.co leg cramps, PATIENT /
plasma is used exposure m/search? myalgia, PARENT
in its prophylaxis in q=hepatitis+b arthralgia. TEACHING
production. selected +vaccine&qs= 5. Health educates
patients and in AS&pq=hepat GI: the mother on the
Reference: infants born to itis&sk=AS2 Nausea, effects of the
https:// HBsAg- &sc=8- vomiting, medication
www.bing.com/ positive 9&cvid=C496 diarrhea. 6. Explain to the
search? mothers 9F15191746A parents the
q=hepatitis+b+v 086924483E4 Skin: rationale/ pupose
accine&qs=AS Reference: CA63BB&FO Rash, of administering
&pq=hepatitis& https:// RM=QBRE&s urticaria, hepa B.
 sk=AS2&sc=8- www.bing.co p=3 pruritus.
9&cvid=C4969 m/search?
F15191746A08 q=hepatitis+b
6924483E4CA6 +vaccine&qs=
3BB&FORM= AS&pq=hepat
QBRE&sp=3 itis&sk=AS2
&sc=8-
9&cvid=C496
9F15191746A
086924483E4
CA63BB&FO
RM=QBRE&s
p=3

ROUTE/ NURSING
NAME OF DRUG/ MECHANISM OF INDICATI CONTRAIND
DOSAGE/ SIDE EFFECT RESPONSIBILIT
MEDICATION ACTION ON ICATION
FREQUENCY Y
GENERIC ROUTE: Causes potent To induce  Hypersen MATERNAL NURSING
NAME: Parenteral (IV) and selective or sitive to CNS: subarachnoid CONSIDERATI
Oxytocin stimulation of stimulate drugs hemorrhage, seizures, ON
uterine and labor. coma
BRAND NAME: DOSAGE: mammary gland  When 1. Observe 10
Pitocin 10 mL smooth muscle. Reference: vaginal CV: arrythmias, HTN, R’s in giving
Nursing delivery PVC’s, hypotension, medication.
Reference: 2021 drug isn’t Tachycardia. 2. Monitor vital
CLASSIFICATI FREQUENCY Nursing 2021 handbook advised signs every 15
ON: : drug handbook (2021).  When GI: nausea, vomiting. minutes.
Therapeutic class: (2021). delivery 3. Monitor I and
1 ml per minute requires GU: abruptio placenta, O
Oxytocics tetanic uterine 4. Never give
transversi
on contractions, drug
 Fetal postpartum simultaneousl
Pharmacologic
distress hemorrhage, uterine y in one more
class:
 In patient rupture, impaired route.
Exogenous with uterine blood flow, 5. Don’t give
Hormones pelvic hematoma, bolus
previous
delivery increased uterine injection, use
via CS. motility. an infusion
Reference: pump via
Nursing HEMATOLOGIC: piggy back.
2021 drug afibrinogenemia, PATIENT /
handbook postpartum bleeding, parents
(2021). pelvic bleeding. TEACHING
6. Explain the
OTHER: anaphylaxis, use and
death, hypersensitivity administration
reactions of drug to
patient and
FETAL
 CNS: infant brain family.
damage, seizures 7. Instruct
patient to
CV: bradycardia, promptly
arrythmia report adverse
effects.
EENT: neonatal retinal
hemorrhage.

HEPATIC: neonatal
jaundice

OTHER: low Apgar

score at 5 mins, death
ROUTE/
NAME OF DRUG/ MECHANISM CONTRAINDICA SIDE NURSING
DOSAGE/ INDICATION
MEDICATION OF ACTION TION EFFECT RESPONSIBILITY
FREQUENCY
GENERIC ROUTE: Magnesium is the - To prevent - Contraindicat CNS: NURSING
NAME: Parenteral (IV) second most pre- ed to patients weakness, CONSIDERATION
plentiful cation of
Magnesium eclampsia/ with allergy to dizziness,
the intracellular
sulfate fluids. It is essential eclampsia magnesium fainting, 1. Observe 10 R’s in
BRAND NAME: DOSAGE: for the activity of - Convulsio products. sweating. giving medication.
Epsom Salt 8-24 mEq many enzyme ns in - To patient’s 2. Assess allergic
systems and plays pregnancy ongoing labor. CV: reactions.
an important role palpitations
CLASSIFICATI FREQUENCY with regard to Reference: Reference: 3. Assess vital signs
ON: : neurochemical Nursing 2021 Nursing 2021 GI: before giving
transmission and
Minirals and elec Once a day drug drug handbook excessive medications,
muscular
excitability. handbook (2021). bowel especially the blood
Magnesium sulfate (2021). activity pressure.
reduces striated perianal 4. Provide cool/ well-
muscle contractions irritations. ventilated
and blocks environment.
peripheral
MATABO 5. Rehydrate the
neuromuscular
transmission by LIC: patient.
reducing hypermagn 6. Monitor Mg levels
acetylcholine esemia, and 7. Calcium gluconate
release at the toxicity in is the antidote.
myoneural junction. patients 8. Monitor EKG and
Additionally,
with renal respiratory status.
Magnesium inhibits
Ca2+ influx failure PATIENT
through TEACHING
dihydropyridine- 9. Explain the
sensitive, voltage- rationale as to why
dependent magnesium sulfate
channels. This
is needed.
accounts for much
of its relaxant 10.Instruct the patient
action on vascular to drink lots of
smooth muscle. water.
11.Inform the patient
Reference: that her temperature
Nursing 2021 may rise due to the
 drug handbook effects of
(2021). medication.
12.Report immediately
if respiratory
distress is present
such as gasping and
difficulty breathing.

ROUTE/
NAME OF DRUG/ MECHANISM OF INDICATIO CONTRAINDI NURSING
DOSAGE/ SIDE EFFECT
MEDICATION ACTION N CATION RESPONSIBILITY
FREQUENCY
GENERIC ROUTE: Hyoscine - Relief in - Hypersensi CNS: dizziness, NURSING
NAME: Parenteral (IV) butylbromide smooth tivity to anaphylactic CONSIDERATIO
reduces smooth muscle hyoscine reactions, N
muscle contraction spasm of butyl anaphylactic
BRAND NAME: DOSAGE: and the production the bromide shock, increased 1. Observe 10 R’s
buscopan 20 mg of respiratory gastroint - Porphyria ICP, in giving
secretions. These estinal - Myastheni disorientation, medication.
are normally system. a gravis restlessness,
CLASSIFICATI FREQUENCY stimulated by the - Abdomi - pyloric irritability, 2. Assess allergic
ON: : parasympathetic nal colic stenosis dizziness, reactions.
Antispasmodic/ nervous system, - Renal Reference: drowsiness, 3. Assess vital
antocholinergic Once via the colic Nursing 2021 headache, signs before
neurotransmitter Reference: drug confusion, taking
acetylcholine. As Nursing handbook hallucination, medications.
an antimuscarinic, 2021 drug (2021). delirium, impaired 4. Monitor urine
hyoscine handbook memory output
butylbromide (2021). CV: hypotension, 5. Avoid strict
binds to tachycardia, heat
muscarinic palpitations,
acetylcholine flushing PATIENT /
receptors, GI: Dry mouth, PARENTS
blocking their constipation, TEACHING
effect nausea, epigastric 1. Explain the
distress procedure and
Reference: DERM: flushing, the rationale as
Nursing 2021 drug dyshidrosis to why
handbook (2021). GU: Urinary medication is
retention, urinary needed.
hesitancy
Resp: dyspnea,
bronchial
plugging,
depressed
respiration
EENT: mydriasis,
dilated pupils,
blurred vision,
photopobia,
increased
intraocular
pressure, difficulty
of swallowing.